Spaulding Clinical Research Named "Best Phase I Drug Development CRO"

Press Release:

International Life Sciences Awards Banner

Spaulding Clinical Research, LLC recognized as the 2016 International Life Sciences Award by Global Health & Pharma, GHP Magazine, for "Best Phase I Drug Development CRO."

The International Life Sciences continue to have a global impact and be captivated by daily breakthroughs that focus on companies, departments, and individuals who truly deserve to be identified as unique in their industry.

As such, Spaulding Clinical Research keeps conducting tests and research, embracing the most advanced technology to forge ahead into clinical research and biometric solutions.

Spaulding's forwarding innovation and excellence are what assures that the life sciences has become more than just another dynamic challenge in the market today.  

 

Meet US @ OCT Southern California 2016

OCT New England 2016 - Outsourcing in Clinical Trials & CTS banner
 
26-27 Oct 2016     //     La Jolla, CA     //     Booth #27  
 
Spaulding Clinical Research, LLC invites you to meet us at OCT Southern California 2016 and learn how our paperless, 200-Bed Phase I Clinic and innovative ECG Core Laboratory technology can accelerate your drug's development.
 
Make sure to ask one of our experts about:
 
1)  Our company's 2015 performance Metrics
2)  How we can reduce site burden and the cost of your study with our latest Cardiac Safety Solution.  Here's a teaser:  View Press Release >>
 
If you can't make the event, make sure to check out some of our latest content:
 
 
If you are attending OCT Southern California 2016 and would like to schedule a meeting, please This email address is being protected from spambots. You need JavaScript enabled to view it. or call us at 1-262-334-6020.
 

Meet Us @ OCT New England 2016

OCT New England 2016 - Outsourcing in Clinical Trials & CTS banner
 
07-08 Sept 2016     //     Boston, MA     //     Booth #18  
 
Spaulding Clinical Research, LLC invites you to meet us at OCT New England 2016 and learn how our paperless, 200-Bed Phase I Clinic and innovative ECG Core Laboratory technology can accelerate your drug's development.
 
Make sure to ask one of our experts about:
 
1)  Our company's 2015 performance Metrics
2)  How we can reduce site burden and the cost of your study with our latest Cardiac Safety Solution.  Here's a teaser:  View Press Release >>
 
If you can't make the event, make sure to check out some of our latest content:
 
 
If you are attending OCT New England 2016 and would like to schedule a meeting, please This email address is being protected from spambots. You need JavaScript enabled to view it. or call us at 1-262-334-6020.